TRANSUNION's ticker is TRU and the CUSIP is 89400J107. A total of 448 filers reported holding TRANSUNION in Q1 2022. The put-call ratio across all filers is 1.09 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,855,186 | +24.7% | 55,929 | +40.3% | 0.01% | +20.0% |
Q2 2023 | $3,091,563 | +18.3% | 39,850 | -5.3% | 0.01% | +25.0% |
Q1 2023 | $2,613,981 | +10.3% | 42,066 | +0.8% | 0.00% | 0.0% |
Q4 2022 | $2,369,313 | +16.0% | 41,750 | +21.6% | 0.00% | 0.0% |
Q3 2022 | $2,042,000 | -24.9% | 34,325 | +1.0% | 0.00% | 0.0% |
Q2 2022 | $2,719,000 | -37.0% | 33,991 | -18.6% | 0.00% | -33.3% |
Q1 2022 | $4,313,000 | +343.3% | 41,734 | +408.8% | 0.01% | +500.0% |
Q4 2021 | $973,000 | +4.0% | 8,202 | -1.6% | 0.00% | 0.0% |
Q3 2021 | $936,000 | +59.5% | 8,334 | +55.8% | 0.00% | 0.0% |
Q2 2021 | $587,000 | +33.1% | 5,349 | +9.2% | 0.00% | 0.0% |
Q1 2021 | $441,000 | +12.2% | 4,898 | +23.8% | 0.00% | 0.0% |
Q4 2020 | $393,000 | +15.2% | 3,956 | -2.3% | 0.00% | 0.0% |
Q3 2020 | $341,000 | -87.7% | 4,050 | -87.3% | 0.00% | -85.7% |
Q2 2020 | $2,777,000 | +721.6% | 31,908 | +524.2% | 0.01% | +600.0% |
Q1 2020 | $338,000 | +29.5% | 5,112 | +68.0% | 0.00% | 0.0% |
Q4 2019 | $261,000 | -11.5% | 3,043 | -24.2% | 0.00% | 0.0% |
Q3 2018 | $295,000 | – | 4,016 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Lansing Management LP | 226,284 | $13,462,000 | 16.72% |
BlueSpruce Investments, LP | 5,983,742 | $355,973,000 | 7.28% |
Incline Global Management LLC | 341,553 | $20,319,000 | 5.67% |
Laurus Investment Counsel Inc. | 153,425 | $12,508,000 | 4.56% |
Independent Franchise Partners LLP | 6,999,306 | $416,388,000 | 4.38% |
WILSON ASSET MANAGEMENT (INTERNATIONAL) PTY LTD | 207,731 | $12,358,000 | 4.16% |
Phase 2 Partners, LLC | 110,872 | $6,596,000 | 3.13% |
HST Ventures, LLC | 76,369 | $4,543,000 | 3.05% |
FARALLON CAPITAL MANAGEMENT LLC | 7,907,895 | $470,441,000 | 2.60% |
CCLA Investment Management | 1,351,078 | $80,459,423,000 | 1.94% |